Drugs With Abuse Potential Should Recruit Two Types Of Patients For Trials
• By The Pink Sheet
FDA is encouraging sponsors conducting clinical trials to assess the abuse potential of a new drug to enroll "drug-naive healthy subjects" as well as "experienced, recreational drug users who have a recent or current history of using a drug in the pharmaceutical class of the test drug.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights